Overview

Intracochlear Platelet-rich Fibrin Application in Cochlear Implantation

Status:
Recruiting
Trial end date:
2022-12-20
Target enrollment:
0
Participant gender:
All
Summary
Fibrosis due to surgical trauma is a common problem with cochlear implants. Fibrosis limits the effectiveness of implant and increases the power consumption. Our aim in this study is to benefit from the anti-inflammatory effects of autologous platelet-rich fibrin to reducing the fibrotic cascade.
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Pamukkale University
Criteria
Inclusion Criteria:

- Patients with sensorineural hearing loss

- Patients who will have cochlear implant surgery with CI422 electrode

Exclusion Criteria:

- Patients with cochlear abnormality

- Patients with auditory neuropathy